Form D · Pharmaceuticals

SKINMEDICA INC

Carlsbad, CA · CIK 0001187545

Offering snapshot reported Jan 13, 2012 · SEC filing

Reported sold
$16.8M
Offering amount: $17.1M
Investors reported
2
Form D · investor count
Minimum accepted
$1
Reported outside-investor minimum
First sale
Jan 6, 2012
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 13, 2012Initial$16,759,991No comparison2SEC filing
Jun 12, 2009Initial$9,438,712No comparison15SEC filing

Offering details

Securities
Equity
Exemptions
06
Duration over one year
No
Business combination
Yes
Sales commissions
$0
Finders' fees
$0
Form D file number
021-171888
Total amount sold may increase as a result of working capital adjustments.

Source: Form D, filed Jan 13, 2012. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Graham D.S. Anderson Director
Christina Balesteri Executive
Rex Bright Director
James H. Cavanaugh, Ph.D. Director
Brian H. Dovey Director
Theodore Ebel Executive
Mary Fisher Director, Executive
Richard E. Fitzpatrick, M.D. Director
David F. Hale Director
Thomas H. Insley Executive
George Jenkins Director
Steve P. Loomis Executive
Adele C. Oliva Director
William A. Roper, Jr. Director
Andrew N. Schiff, M.D. Director
Theodore Schwarz Executive
Rob Sorensen Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
5909 Sea Lion Place Suite H
Carlsbad, CA, 92010